The Patent Finder

Fidia Farmaceutici S.P.A.

Also on record
Records under this name other than the patents Fidia Farmaceutici S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 58 patents it holds.

Back to Fidia Farmaceutici S.P.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,273,063Method for Preparing a Rifaximin Product
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,935,818Process for the preparation and purification of valgancyclovir hydrochloride
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,519,160Process for the preparation of rotigotine
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,603,910Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
Term ended
Term ended Jul 5, 2026 · USPTO record
Term endedTerm ended Jul 5, 2026USPTO record
US 11,040,089Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
Term ended
Ended no later than Jul 5, 2026 · USPTO record
Term endedEnded no later than Jul 5, 2026USPTO record
US 8,765,714Sulphated Hyaluronic Acid for Treating Degenerative Osteoarthritis
No holder on record
Lapsed on the fee record
Ended Jul 1, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 1, 2026Medium confidence
US 8,512,752Hyaluronic acid derivatives obtained via “click chemistry” crosslinking
Lapsed on the fee record
Ended Aug 20, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 20, 2025USPTO record
US 7,838,510Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors
Term ended
Term ended Jan 5, 2025 · USPTO record
Term endedTerm ended Jan 5, 2025USPTO record
US 7,897,584Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
Term ended
Term ended Jan 4, 2025 · USPTO record
Term endedTerm ended Jan 4, 2025USPTO record
US 7,462,606Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
Term ended
Term ended Sep 16, 2024 · USPTO record
Term endedTerm ended Sep 16, 2024USPTO record
10 of 62 patents shown.
Pro members see all 62.
Pro members: see all 62 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited